Swarajya

Our View
HeadlinesMagazineVideosBooksस्वराज्यEconomyCultureEvents
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief
  • Subscriber login
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief

FDA

FDA Okays Pfizer-BioNTech's Covid-19 Vaccine For Children Aged 5 To 11
FDA Okays Pfizer-BioNTech's Covid-19 Vaccine For Children Aged 5 To 11Bhaswati Guha Majumder Oct 30, 2021 04:27 PM +05:30 IST
US Health Officials Are Investigating Moderna Covid-19 Vaccine For Higher Heart Inflammation Risk
US Health Officials Are Investigating Moderna Covid-19 Vaccine For Higher Heart Inflammation RiskBhaswati Guha Majumder Aug 20, 2021 03:27 PM +05:30 IST
Novavax Is Facing Funding Issues In The US But Seeking Emergency Approval In Needy Countries
Novavax Is Facing Funding Issues In The US But Seeking Emergency Approval In Needy CountriesBhaswati Guha Majumder Aug 6, 2021 02:08 PM +05:30 IST
Guillain-Barre Syndrome: FDA Issues Warning On Johnson & Johnson's Covid-19 Vaccine Linked To Rare Disorder
Guillain-Barre Syndrome: FDA Issues Warning On Johnson & Johnson's Covid-19 Vaccine Linked To Rare Disorder Bhaswati Guha Majumder Jul 14, 2021 06:42 PM +05:30 IST
Pfizer Wants Approval For Covid-19 Booster Shot; FDA, CDC Don't See The Necessity
Pfizer Wants Approval For Covid-19 Booster Shot; FDA, CDC Don't See The NecessityBhaswati Guha Majumder Jul 12, 2021 12:18 PM +05:30 IST
After FDA's Recommendation, Ocugen To Seek Full Approval For Bharat Biotech's Covaxin In US
After FDA's Recommendation, Ocugen To Seek Full Approval For Bharat Biotech's Covaxin In USSwarajya StaffJun 11, 2021 10:56 AM +05:30 IST
US Researchers Start Clinical Trials To Test Mix-And-Match Covid Vaccine Boosters
US Researchers Start Clinical Trials To Test Mix-And-Match Covid Vaccine BoostersIANSJun 3, 2021 12:45 PM +05:30 IST
FDA Authorises Moderna's Covid-19 Vaccine For Emergency Use; Two Vaccines Greenlighted In A Week
FDA Authorises Moderna's Covid-19 Vaccine For Emergency Use; Two Vaccines Greenlighted In A WeekSwarajya StaffDec 19, 2020 08:29 AM +05:30 IST
After Pfizer, Moderna's Covid-19 Vaccine Nears Approval As FDA Confirms Safety In Preliminary Analysis
After Pfizer, Moderna's Covid-19 Vaccine Nears Approval As FDA Confirms Safety In Preliminary AnalysisIANSDec 16, 2020 09:46 AM +05:30 IST
US FDA Greenlights Emergency Use Of First At-Home Rapid Covid-19 Test
US FDA Greenlights Emergency Use Of First At-Home Rapid Covid-19 TestIANSNov 18, 2020 10:41 AM +05:30 IST
Explained: Yale’s Saliva-based COVID-19 Test That Promises Rapid Detection Of Coronavirus At Low Cost
Explained: Yale’s Saliva-based COVID-19 Test That Promises Rapid Detection Of Coronavirus At Low CostKaran KambleAug 17, 2020 06:33 PM +05:30 IST
 Fitbit Introduces Low-Cost Emergency Ventilator ‘Fitbit Flow’ For Covid-19 Patients
Fitbit Introduces Low-Cost Emergency Ventilator ‘Fitbit Flow’ For Covid-19 PatientsIANSJun 4, 2020 01:38 PM +05:30 IST
US FDA Approves Emergency Use Of Anti-Viral Drug Remdesivir For Covid-19 Patients
US FDA Approves Emergency Use Of Anti-Viral Drug Remdesivir For Covid-19 PatientsIANSMay 2, 2020 11:14 AM +05:30 IST
One Each For Import And Export: How Over-Dependence On China And US Markets Blocks Indian Pharma’s Growth
One Each For Import And Export: How Over-Dependence On China And US Markets Blocks Indian Pharma’s Growth Karan BhasinApr 16, 2020 03:50 PM +05:30 IST
US FDA Authorises Blood Purification Device To Treat COVID-19 Patients With Serious Conditions
US FDA Authorises Blood Purification Device To Treat COVID-19 Patients With Serious ConditionsSwarajya StaffApr 11, 2020 11:54 AM +05:30 IST
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Advertise
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype